JPML Asked to Centralize Lawsuits Over Insulin Pricing Scheme
Lawsuits allege the insulin pricing scheme leads to states and consumers paying $300 to $700 for doses, which cost the drug makers just $2 to produce.
Lawsuits allege the insulin pricing scheme leads to states and consumers paying $300 to $700 for doses, which cost the drug makers just $2 to produce.
Rebates disguised as "administrative fees" and other costs lead to an illegal insulin pricing scheme which costs consumers and the healthcare system billions of dollars, the lawsuit claims
The ruling means some California Zantac lawsuits are likely to go to before juries in the coming months, while appeals move forward over a controversial decision in the federal court system to exclude all plaintiffs' expert testimony.
Zantac lawsuit filings have shifted to New York and other state courts, after a federal judge issued a ruling last month that resulted in dismissal of the litigation.
The federal dismissal does not directly affect Zantac lawsuits filed in state courts nationwide, where cases are scheduled to go to trial throughout 2023
Manufacturers still face about 50,000 Zantac cancer lawsuits in state courts, and reached a settlement instead of allowing a jury to hear evidence in a California Zantac trial scheduled to begin in Feb 2023
Plaintiffs plan to appeal the decision, maintaining that there is more than sufficient evidence about the link between Zantac and cancer to allow juries to consider lawsuits
Research published last month highlight the link between various cancers and Zantac, including liver, lung, gastric and pancreatic cancers.
Zantac cancers supported in the federal courts are limited to bladder, esophageal, gastric, liver and pancreatic. Thousands of other lawsuits are being filed in state courts involving breast, kidney, colorectal, prostate, and other cancers.
Zantac Daubert hearings will be held by the judge to determine whether proposed expert witness testimony about the risk of specific cancers from Zantac is sufficiently sound to present to a jury.